While the NLRP3 inflammasome, the most extensively investigated member of the NLR family, has been closely linked to HCC progression [30,31], and various gene set-based investigations have aimed to predict HCC prognosis and the immune microenvironment for clinical decision-making [32,33]. Here, NLRP3 is linked to hepatocellular carcinoma.